[Enzalutamide (prostate cancer) - Addendum to Commission A21-77]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003996
German
Original Title: Enzalutamid (Prostatakarzinom) - Addendum zum auftrag A21-77
Details
Project Status: Completed
Year Published: 2021
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Prostatic Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
  • Antineoplastic Agents
  • Androgen Antagonists
Keywords
  • Enzalutamide
  • Prostatic Neoplasms
  • Benefit Assessment
  • NCT02677896
  • NCT00268476
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.